NCT04007289 - Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension | Biotech Hunter

Enrollment

166

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions

Intrahepatic Non Cirrhotic Portal Hypertension

Interventions

DRUG

Apixaban

Administration of Apixaban ; 2 clinical examinations; blood tests, 3 liver and spleen stiffness measurements, 2 contrast enhanced echocardiographies, 1 hepatic ultrasonography, Biological samples collections to identify predictors of thrombosis and liver related events

DRUG

Placebo

Administration of placebo ; 2 clinical examinations; blood tests, 3 liver and spleen stiffness measurements, 2 contrast enhanced echocardiographies, 1 hepatic ultrasonography,

Trial Locations (1)

92110

Beaujon hospital, Clichy

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER